EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review

Detalhes bibliográficos
Autor(a) principal: Silva, Paloma Lara Ferreira
Data de Publicação: 2023
Outros Autores: Amâncio, Natália de Fátima Gonçalves, Pereira Tolentino, Vanessa
Tipo de documento: Artigo
Idioma: por
Título da fonte: Brazilian Journal of Implantology and Health Sciences
Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/1066
Resumo: Introduction: Autism Spectrum Disorder (ASD) is characterized as a neurological condition with complex causes, potentially affecting social interactions and manifesting repetitive behaviors. Cannabidiol (CBD), a non-intoxicating component of the cannabis plant, shows therapeutic potential for relieving these symptoms safely and with minimal side effects, thereby improving the quality of life and daily functioning in individuals with ASD. Objective: This systematic review aims, through controlled studies, case reports, and reviews, to understand and describe the benefits and drawbacks of the relationship between individuals with ASD and the therapeutic use of CBD. Methodology: In this literature review, descriptors in Portuguese, English, and Spanish were used for bibliographic searches on databases such as Google Scholar, SciELO, PubMed, and BVS in September 2023. Inclusion criteria restricted articles to the last 5 years, published in Portuguese or English. Out of the initially identified 277 articles, 20 were selected. Results: The findings highlight improvements in social interaction, behavioral symptoms, and sleep quality with the use of CBD. However, there are reports of adverse effects such as drowsiness and decreased appetite, yet the majority of studies deem CBD to be safe. Conclusion: The research emphasizes the lack of a specific pharmacological treatment for ASD but underscores the importance of CBD as a complementary therapy, given the notable benefits and mild complications observed with the use of this substance. It further highlights the need for more medical and scientific research to better understand the effectiveness and potential adverse effects of CBD therapy in ASD.  
id GOE-1_6aba6abb32460ab19fe8973c6e401e85
oai_identifier_str oai:ojs.bjihs.emnuvens.com.br:article/1066
network_acronym_str GOE-1
network_name_str Brazilian Journal of Implantology and Health Sciences
repository_id_str
spelling EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative reviewANÁLISE DA EFICÁCIA DO CANABIDIOL NO TRANSTORNO DO ESPECTRO AUTISTA: revisão integrativaTranstorno do Espectro AutistaCanabidiol (CBD)terapia complementarIntroduction: Autism Spectrum Disorder (ASD) is characterized as a neurological condition with complex causes, potentially affecting social interactions and manifesting repetitive behaviors. Cannabidiol (CBD), a non-intoxicating component of the cannabis plant, shows therapeutic potential for relieving these symptoms safely and with minimal side effects, thereby improving the quality of life and daily functioning in individuals with ASD. Objective: This systematic review aims, through controlled studies, case reports, and reviews, to understand and describe the benefits and drawbacks of the relationship between individuals with ASD and the therapeutic use of CBD. Methodology: In this literature review, descriptors in Portuguese, English, and Spanish were used for bibliographic searches on databases such as Google Scholar, SciELO, PubMed, and BVS in September 2023. Inclusion criteria restricted articles to the last 5 years, published in Portuguese or English. Out of the initially identified 277 articles, 20 were selected. Results: The findings highlight improvements in social interaction, behavioral symptoms, and sleep quality with the use of CBD. However, there are reports of adverse effects such as drowsiness and decreased appetite, yet the majority of studies deem CBD to be safe. Conclusion: The research emphasizes the lack of a specific pharmacological treatment for ASD but underscores the importance of CBD as a complementary therapy, given the notable benefits and mild complications observed with the use of this substance. It further highlights the need for more medical and scientific research to better understand the effectiveness and potential adverse effects of CBD therapy in ASD.  Introdução: O Transtorno do Espectro Autista (TEA) é caracterizado como uma condição neurológica com causas complexas, podendo afetar as interações sociais e manifestar comportamentos repetitivos. O Canabidiol (CBD), componente não intoxicante da planta cannabis, apresenta um potencial terapêutico para o alivio desses sintomas de forma segura e com baixos efeitos colaterais, melhorando a qualidade de vida e o funcionamento diário em pessoas com TEA. Objetivo: Esta revisão sistemática tem como objetivo, a partir de estudos controlados, relatos de casos e revisões, entender e descrever os benefícios e os malefícios da relação entre os pacientes com TEA e o uso terapêutico do CBD. Metodologia: Nesta revisão de literatura, foram utilizados descritores em português, inglês e espanhol para a busca bibliográfica em bases de dados como Google Scholar, SciELO, PubMed e BVS, no período de setembro de 2023. Os critérios de inclusão limitaram os artigos aos últimos 5 anos, publicados em português ou inglês. Dos 277 artigos inicialmente identificados, 20 foram selecionados. Resultados: Os resultados evidenciam melhorias na interação social, nos sintomas comportamentais e na qualidade do sono com o uso de CBD. No entanto, há relatos de efeitos adversos, como sonolência e diminuição do apetite, mas, a maioria dos estudos consideram o CBD seguro. Conclusão:  A pesquisa destaca a falta de tratamento farmacológico específico para o TEA, porém enfatiza a importância do CBD como terapia complementar, visto que é observado benefícios notáveis e complicações leves no uso dessa substância. Ressalta-se ainda a necessidade de mais pesquisas médicas e científicas para compreender melhor a eficácia e os possíveis efeitos adversos da terapia com CBD no TEA.  Specialized Dentistry Group2023-12-19info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/106610.36557/2674-8169.2023v5n5p5859-5873Brazilian Journal of Implantology and Health Sciences ; Vol. 5 No. 5 (2023): BJIHS QUALIS B3; 5859-5873Brazilian Journal of Implantology and Health Sciences ; Vol. 5 Núm. 5 (2023): BJIHS QUALIS B3; 5859-5873Brazilian Journal of Implantology and Health Sciences ; v. 5 n. 5 (2023): BJIHS QUALIS B3; 5859-58732674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1066/1265Copyright (c) 2023 Paloma Lara Ferreira Silva, Natália de Fátima Gonçalves Amâncio, Vanessa Pereira Tolentinohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Paloma Lara FerreiraAmâncio, Natália de Fátima Gonçalves Pereira Tolentino, Vanessa2023-12-19T11:04:16Zoai:ojs.bjihs.emnuvens.com.br:article/1066Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2023-12-19T11:04:16Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false
dc.title.none.fl_str_mv EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review
ANÁLISE DA EFICÁCIA DO CANABIDIOL NO TRANSTORNO DO ESPECTRO AUTISTA: revisão integrativa
title EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review
spellingShingle EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review
Silva, Paloma Lara Ferreira
Transtorno do Espectro Autista
Canabidiol (CBD)
terapia complementar
title_short EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review
title_full EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review
title_fullStr EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review
title_full_unstemmed EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review
title_sort EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review
author Silva, Paloma Lara Ferreira
author_facet Silva, Paloma Lara Ferreira
Amâncio, Natália de Fátima Gonçalves
Pereira Tolentino, Vanessa
author_role author
author2 Amâncio, Natália de Fátima Gonçalves
Pereira Tolentino, Vanessa
author2_role author
author
dc.contributor.author.fl_str_mv Silva, Paloma Lara Ferreira
Amâncio, Natália de Fátima Gonçalves
Pereira Tolentino, Vanessa
dc.subject.por.fl_str_mv Transtorno do Espectro Autista
Canabidiol (CBD)
terapia complementar
topic Transtorno do Espectro Autista
Canabidiol (CBD)
terapia complementar
description Introduction: Autism Spectrum Disorder (ASD) is characterized as a neurological condition with complex causes, potentially affecting social interactions and manifesting repetitive behaviors. Cannabidiol (CBD), a non-intoxicating component of the cannabis plant, shows therapeutic potential for relieving these symptoms safely and with minimal side effects, thereby improving the quality of life and daily functioning in individuals with ASD. Objective: This systematic review aims, through controlled studies, case reports, and reviews, to understand and describe the benefits and drawbacks of the relationship between individuals with ASD and the therapeutic use of CBD. Methodology: In this literature review, descriptors in Portuguese, English, and Spanish were used for bibliographic searches on databases such as Google Scholar, SciELO, PubMed, and BVS in September 2023. Inclusion criteria restricted articles to the last 5 years, published in Portuguese or English. Out of the initially identified 277 articles, 20 were selected. Results: The findings highlight improvements in social interaction, behavioral symptoms, and sleep quality with the use of CBD. However, there are reports of adverse effects such as drowsiness and decreased appetite, yet the majority of studies deem CBD to be safe. Conclusion: The research emphasizes the lack of a specific pharmacological treatment for ASD but underscores the importance of CBD as a complementary therapy, given the notable benefits and mild complications observed with the use of this substance. It further highlights the need for more medical and scientific research to better understand the effectiveness and potential adverse effects of CBD therapy in ASD.  
publishDate 2023
dc.date.none.fl_str_mv 2023-12-19
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://bjihs.emnuvens.com.br/bjihs/article/view/1066
10.36557/2674-8169.2023v5n5p5859-5873
url https://bjihs.emnuvens.com.br/bjihs/article/view/1066
identifier_str_mv 10.36557/2674-8169.2023v5n5p5859-5873
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://bjihs.emnuvens.com.br/bjihs/article/view/1066/1265
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Specialized Dentistry Group
publisher.none.fl_str_mv Specialized Dentistry Group
dc.source.none.fl_str_mv Brazilian Journal of Implantology and Health Sciences ; Vol. 5 No. 5 (2023): BJIHS QUALIS B3; 5859-5873
Brazilian Journal of Implantology and Health Sciences ; Vol. 5 Núm. 5 (2023): BJIHS QUALIS B3; 5859-5873
Brazilian Journal of Implantology and Health Sciences ; v. 5 n. 5 (2023): BJIHS QUALIS B3; 5859-5873
2674-8169
reponame:Brazilian Journal of Implantology and Health Sciences
instname:Grupo de Odontologia Especializada (GOE)
instacron:GOE
instname_str Grupo de Odontologia Especializada (GOE)
instacron_str GOE
institution GOE
reponame_str Brazilian Journal of Implantology and Health Sciences
collection Brazilian Journal of Implantology and Health Sciences
repository.name.fl_str_mv Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)
repository.mail.fl_str_mv journal.bjihs@periodicosbrasil.com.br
_version_ 1796798442192764928